RiverPark opened a new position in Northrop Grumman Corporation (NYSE:NOC) during the fourth quarter of 2017. In its Long/Short Opportunity Fund Q4 Investor Letter, the fund noted that Northrop Grumman is “well positioned to benefit from U.S. defense budget growth.” President Donald Trump’s 2019 budget request includes $686 billion for defense spending – obviously NOC is among the top companies that could get a massive benefit from the military spending. In this article, we’ll take a look at Northrop Grumman’s performance and RiverPark’s investment thesis about the company.
Here is what RiverPark said about Northrop Grumman:
Finally, we also established a small position in Northrop Grumman, one of the largest aerospace and defense contractors in the U.S. With about 85% of its $25 billion in revenue from the U.S. government, the company is well positioned to benefit from U.S. defense budget growth, historically 5-6% per year.
With about 20% of its revenue coming from aircraft programs, such as the B-21, E-2D, and the F-35, which are growing at more than 20% per year, we believe the company could grow at a significantly higher rate than overall defense budget growth over the next several years.
We expect the company’s growth will be further enhanced by the recently announced acquisition of Orbital-ATK, a leading niche developer of advance weapons and space systems. This acquisition improves the combined company’s position in the faster growing military aerospace and missile defense industry and fills a gap in Northrop Grumman’s offerings in satellites and space systems. Additionally, Northrop Grumman is one of only two large defense companies bidding for the $100 billion Ground-Based Strategic Deterrent intercontinental ballistic missile weapon system program (GBSD), expected to be awarded in 2019. With Orbital positioned as the bidding subcontractor to both teams (for about 20% of the program), we believe the odds of Northrop Grumman winning the GBSD program have increased.
The street expects mid-to-high single-digit revenue growth for the company, relatively in-line with budget growth. Due to its faster-growing program exposure, plus the potential win of the GBSD program, we believe the company can comfortably exceed that growth rate. Margin expansion from increased scale can drive double-digit operating income growth; strategic acquisitions, debt pay down and continued share buybacks from $2 billion per year of free cash flow should lead to even greater EPS growth.
Michael Fitzsimmons/Shutterstock.com
Northrop Grumman Corporation (NYSE:NOC) is a $62-billion market cap aerospace and defense technology company that manufactures various military equipment in autonomous, cyber, C4ISR, strike, and logistics areas. The company generated a total revenue of $25.8 in 2017, $24.5 billion in 2016, and $23.5 billion in 2015.
Last week, Northrop Grumman announced that its proposed-acquisition of Orbital ATK (NYSE:OA) was approved by the European Commission. In September of the last year, Northrop Grumman announced a deal to acquire Orbital ATK for about $7.8 billion in cash. Orbital is a maker of aerospace and defense technologies. The acquisition, which is expected to close in the first half of 2018, is being reviewing by the U.S. Federal Trade Commission’s review of the acquisition.
Shares of Northrop Grumman are up around 16% since the start of the year. Over the past 12 months, the stock has gained 46.15%. NOC has a consensus average rating of ‘Overweight’ and a consensus price target of $353.67 on the stock, which was closed at $356 on Friday.
Meanwhile, Northrop Grumman Corporation (NYSE:NOC) is also favorite stock among the hedge funds tracked by Insider Monkey. As of the end of the third quarter of 2017, there were 36 hedge funds in our database that hold shares of the company.
Warren Buffett never mentions this but he is one of the first hedge fund managers who unlocked the secrets of successful stock market investing. He launched his hedge fund in 1956 with $105,100 in seed capital. Back then they weren’t called hedge funds, they were called “partnerships”. Warren Buffett took 25% of all returns in excess of 6 percent.
For example S&P 500 Index returned 43.4% in 1958. If Warren Buffett’s hedge fund didn’t generate any outperformance (i.e. secretly invested like a closet index fund), Warren Buffett would have pocketed a quarter of the 37.4% excess return. That would have been 9.35% in hedge fund “fees”.
Actually Warren Buffett failed to beat the S&P 500 Index in 1958, returned only 40.9% and pocketed 8.7 percentage of it as “fees”. His investors didn’t mind that he underperformed the market in 1958 because he beat the market by a large margin in 1957. That year Buffett’s hedge fund returned 10.4% and Buffett took only 1.1 percentage points of that as “fees”. S&P 500 Index lost 10.8% in 1957, so Buffett’s investors actually thrilled to beat the market by 20.1 percentage points in 1957.
Between 1957 and 1966 Warren Buffett’s hedge fund returned 23.5% annually after deducting Warren Buffett’s 5.5 percentage point annual fees. S&P 500 Index generated an average annual compounded return of only 9.2% during the same 10-year period. An investor who invested $10,000 in Warren Buffett’s hedge fund at the beginning of 1957 saw his capital turn into $103,000 before fees and $64,100 after fees (this means Warren Buffett made more than $36,000 in fees from this investor).
As you can guess, Warren Buffett’s #1 wealth building strategy is to generate high returns in the 20% to 30% range.
We see several investors trying to strike it rich in options market by risking their entire savings. You can get rich by returning 20% per year and compounding that for several years. Warren Buffett has been investing and compounding for at least 65 years.
So, how did Warren Buffett manage to generate high returns and beat the market?
In a free sample issue of our monthly newsletter we analyzed Warren Buffett’s stock picks covering the 1999-2017 period and identified the best performing stocks in Warren Buffett’s portfolio. This is basically a recipe to generate better returns than Warren Buffett is achieving himself.
You can enter your email below to get our FREE report. In the same report you can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12-24 months. We initially share this idea in October 2018 and the stock already returned more than 150%. We still like this investment.
Free Report Reveals
Warren Buffet's Secret Recipe
Our Price: $199FREE
We may use your email to send marketing emails about our services. Click here to read our privacy policy.